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Abstract
The murine model of T. cruzi infection has provided compelling evidence that development of host resistance against
intracellular protozoans critically depends on the activation of members of the Toll-like receptor (TLR) family via the MyD88
adaptor molecule. However, the possibility that TLR/MyD88 signaling pathways also control the induction of
immunoprotective CD8+ T cell-mediated effector functions has not been investigated to date. We addressed this question
by measuring the frequencies of IFN-c secreting CD8+ T cells specific for H-2Kb-restricted immunodominant peptides as well
as the in vivo Ag-specific cytotoxic response in infected animals that are deficient either in TLR2, TLR4, TLR9 or MyD88
signaling pathways. Strikingly, we found that T. cruzi-infected Tlr22/2, Tlr42/2, Tlr92/2 or Myd882/2 mice generated both
specific cytotoxic responses and IFN-c secreting CD8+ T cells at levels comparable to WT mice, although the frequency of
IFN-c+CD4+ cells was diminished in infected Myd882/2 mice. We also analyzed the efficiency of TLR4-driven immune
responses against T. cruzi using TLR4-deficient mice on the C57BL genetic background (B6 and B10). Our studies
demonstrated that TLR4 signaling is required for optimal production of IFN-c, TNF-a and nitric oxide (NO) in the spleen of
infected animals and, as a consequence, Tlr42/2 mice display higher parasitemia levels. Collectively, our results indicate that
TLR4, as well as previously shown for TLR2, TLR9 and MyD88, contributes to the innate immune response and, consequently,
resistance in the acute phase of infection, although each of these pathways is not individually essential for the generation of
class I-restricted responses against T. cruzi.
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Introduction
T. cruzi is an intracellular protozoan parasite that causes
Chagas’ disease, an endemic disorder affecting 16–20 million
people which remains a health problem in Latin America.
Although both innate and acquired immune responses are
triggered during early infection and are critical for host survival,
around 5% of individuals die due to myocarditis during the acute
phase of the disease. In most cases, despite of the immune
response, T. cruzi manages to subsist within the host and in
approximately 30% of infected individuals it establishes a lifelong
chronic illness presenting different clinical forms, including
cardiomyopathy and megasyndrome in the gut [1]. Immunopa-
thology due to parasite persistence is considered a key element in
the development of chagasic cardiomyopathy, although a
secondary role for autoimmunity is not completely excluded.
Different members of the family of Toll-like receptors (TLRs),
by recognizing diverse pathogen-associated molecular patterns
(PAMPs) of bacterial, viral, fungal, and protozoan origin trigger
the activation of innate immunity and the subsequent development
of Ag-specific adaptive immunity [2]. To date, TLR2, TLR4, and
TLR9 have been implicated in recognition of different T. cruzi-
derived PAMPs [3–6]. TLR2 recognizes GPI-anchors of mucin-
like proteins and the T. cruzi-released protein Tc52 [3,4], whereas
TLR4 is responsible for recognition of free glycoinositolpho-
spholipids [5] and TLR9 is involved in recognition of the CpG
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motif present in T. cruzi DNA [6]. Mice deficient in MyD88, the
adaptor molecule required for signaling events by most TLRs as
well as IL-1R and IL-18R, show greatly enhanced susceptibility to
infection with this protozoan parasite [7]. The susceptibility to
infection of Tlr22/, Tlr92/2 and Tlr22/Tlr92/2 double knockout
mice (all in the C57BL/6 background) has also been analyzed
[6,7]. Interestingly, although mice simultaneously lacking TLR2
and TLR9 are highly vulnerable to infection, their mortality rate is
still less than that of Myd882/2 mice, pointing to the involvement
of other TLRs and/or IL-1/IL-18 in the control of mortality.
In addition to MyD88-dependent activation, another transduc-
tion pathway is involved in signaling through TLR3 and TLR4.
This pathway is mediated by the TIR domain-containing adaptor
inducing IFN-c (TRIF). Interestingly, Myd882/2Trif2/2 and
Myd882/2Ifnar2/2 double knock out mice were even more
sensitive to in vivo infection with T. cruzi than Myd882/2 mice,
indicating that in addition to MyD88-dependent induction of
proinflammatory cytokines, the TRIF-dependent production of
type I IFN also contributes resistance to T. cruzi infection [8]. In
accord with this observation, we have previously demonstrated
that the lack of expression of functional TLR4 in mice of C3H
background caused higher parasitemia and accelerated mortality
to T. cruzi infection [5], although the mechanisms by which this
occurs are not yet fully determined. However, since C3H WT
mice are known to be more susceptible to T. cruzi infection when
compared to mice of the C57BL strains, the direct comparison
between the levels of susceptibility of C3H/HeJ (TLR4-deficient)
mice and the other above mentioned Tlr2/2 and Myd882/2 mice
is difficult to interpret.
Therefore, one of the aims of the present work was to analyze
the role of TLR4 in the C57BL background in the innate response
to T. cruzi. For this, host cell invasion, parasite survival and release
from infected macrophages, as well as nitric oxide (NO)
production were quantified in C57BL/6 (WT) and TLR4-
deficient cell cultures. We also evaluated the contribution of
TLR4 to the in vivo control of parasitemia levels and survival, as
well as to IFN-c and TNF-a production in the B6 and B10
backgrounds. Importantly, the participation of TLR2, TLR4,
TLR9 and MyD88 in the induction of crucial effector mechanisms
of the adaptive response against T. cruzi was also investigated,
measured as the Ag-specific IFN-c production and cytotoxic
response mediated by CD8+ T cells in infected mice.
Results
Defective early trypanosomicidal mechanism in
TLR4-deficient macrophages
In order to compare the anti-T. cruzi microbicidal activity of
WT and TLR4-deficient macrophages, it was first necessary to
investigate whether the infection rate and parasite load were
equivalent in both cases. Therefore we first compared the capacity
of T. cruzi trypomastigotes to infect TLR4-deficient and WT
macrophage (MO) cultures in three different genetic backgrounds:
C3H, C57BL/10 and C57BL/6. Strains C3H/HeJ and C57BL/
10ScN are natural mutants in which the Tlr4 gene suffered
mutations that result either in a residue substitution (P712H),
rendering the receptor non-functional, or a deletion, with non-
expression of TLR4, respectively [9]. Engineered Tlr42/2 in the
B6 background was also previously described [10]. As shown in
Figure 1A, no difference in the percentage of infected macro-
phages or in the number of parasites per macrophage after one
hour of infection could be detected between cultures from the
TLR4-deficient strains and their respective WT controls. Howev-
er, when non-internalized parasites were extensively washed out
after 1 h of interaction and the cultures were left to continue for
three more hours, a significantly higher percentage of infected MO
was found in TLR4-mutant cultures (Fig. S1). This result suggests
the existence of an early microbicidal mechanism which is
dependent on a functional TLR4. In agreement with that, the
number of trypomastigotes released in the supernatant after the
parasite completes its intracellular cycle in long-term cultures is
significantly higher in the TLR4-deficient MO cultures (Fig. 1B–
G). This is true for T. cruzi Y (Fig. 1C–G) and CL strains (Fig. 1B)
and for both resident and elicited macrophages (Fig. 1F and 1G).
Together these results indicated that although cell invasion by the
parasite is not affected by the absence of a functional TLR4, T.
cruzi growth is favored in TLR4-deficient MO, possibly due to a
defective early anti-trypanosomacidal mechanism in TLR4-
deficient MO.
TLR4 and T. cruzi colocalization in lysosomes of host cells
The expression of fluorescent TLR4 in cell lines allowed us to
map TLR4 subcellular location, demonstrating its presence on the
cellular surface and in the Golgi, similar to the TLR4 distribution
observed in human monocytes [11]. It is also known that early
after cell invasion the T. cruzi localizes in a host cell vacuole which
fuses with peripheral lysosomes. HEK293 cells stably transfected
with TLR4-yellow fluorescent protein and MD-2 (HEK-
TLR4YFP) were infected with labeled T. cruzi trypomastigotes
and 2.5 h later we analyzed parasite-TLR4 co-localization by
confocal microscopy. Staining these infected cells with a lysosome
probe also revealed that T. cruzi-TLR4 co-localization occurs in
acidic compartments (Figure 2).
iNOS inhibition in infected WT macrophages leads to an
increase in the number of released trypomastigotes
equaling non-treated Tlr42/2 macrophages
Both NO and reactive oxygen species (ROS) have been shown
to mediate T. cruzi killing [12–15]. Thus, we next analyzed the
effects of adding NO and/or ROS inhibitors to the MO cultures
Author Summary
Innate and acquired immune responses are triggered
during infection with T. cruzi, the etiologic agent of
Chagas’ disease, and are critical for host survival. Parasite
burden is usually controlled by the time the adaptive
response becomes operational. Nevertheless, T. cruzi
manages to subsist within intracellular niches and
establishes a chronic infection, leading to the develop-
ment of cardiomyopathy in approximately one-third of
infected individuals. Recently, Toll-like receptors (TLRs)
have been shown to recognize T. cruzi molecules and mice
lacking MyD88, the key adaptor for most TLRs, are
extremely susceptible to infection. Although TLRs are
known to link innate and adaptive responses, their role in
the establishment of crucial effector mechanisms mediat-
ed by CD8+ T cells during T. cruzi infection has not yet
been determined. We analyzed the induction of IFN-c and
cytotoxic activity in vivo in TLR2-, TLR4-, TLR9- or MyD88-
deficient mice during infection, and found intact responses
compared to WT mice. We also demonstrated that TLR4 is
required for optimal production of inflammatory cytokines
and nitric oxide and, consequently, for a better control of
parasitemia levels. Understanding how TLR activation
leads to resistance to infection might contribute to the
development of better strategies to improve immune
responses against this pathogen.
Cytotoxic CD8 Response to T. cruzi in Myd882/2 Mice
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during infection. Figure 3A shows that the addition of desferrox-
amine (DFO), an iron chelator which can also act as a free radical
scavenger [16], causes a significant increase in the percentage of
infected WT MO. This treatment abolishes the otherwise
significant difference found in the percentage of infected MO
between the non-treated WT and TLR4-deficient cultures. The
same results are obtained when the inducible NO synthase (iNOS)
inhibitor L-NMMA, or the combination of DFO and L-NMMA
are added to these cultures. In order to further confirm the
relevance of this early microbicidal mechanism, absent in TLR4-
deficient MO, we tested the effect of inhibiting NO production in
long term MO cultures, in which the number of parasites released
by infected cells in the supernatant was evaluated several days after
initial infection. As shown in Figure 3B, while iNOS inhibition had
no effect in the number of parasites released by Tlr42/2 MO
cultures, the addition of L-NMMA to the infected WT MO raised
the number of trypomastigotes found in the supernatants to the
levels observed in the Tlr42/2 MO cultures. In contrast, the
addition of rIFN-c an iNOS inducer to the MO cultures from the
beginning of infection reduces the quantity of free trypomastigotes
and results in equal numbers of released parasites from WT or
TLR4-deficient MO (Fig. S2). Together, these results strongly
suggest that the early trypanosomacidal mechanism absent in
TLR4-deficient MO depends on ROS and NO induction.
Higher parasitemia and mortality in TLR4-deficient mice
of C57BL background
We next compared parasitemia and mortality between different
pairs of WT and TLR4-deficient mice (B10 or B6 versus B10/ScN
or Tlr4 KO, respectively), after i.p. infection with 26103 T. cruzi
strain Y bloodstream trypomastigotes. Results in Figures 4A-C and
4D-F show that in both cases we found significantly higher
parasitemia levels in TLR4-deficient mice, although the levels of
parasites in the blood returned to very low or undetectable levels
by day 11–12 post-infection and did not rise again, differently
from what was previously described for C3H/HeJ mice, in which
parasitemia levels were not controlled after day 15 pi [5]. We
further monitored the mortality after infection and found that
TLR4-deficiency in both B10 and B6 backgrounds results in
higher lethality. Statistically significant differences, however, were
consistently found only when comparing B10 and B10/ScN mice,
while results with B6 and Tlr42/2 were more variable and did not
reach statistical significance (Figure 4G and H). Of note, these
results were obtained in male mice of 6–7 weeks of age, while in
older TLR4-deficient mice the higher susceptibility could not be
observed (data not shown). We have also performed experiments
with lower (102) and higher (104 and 105) doses of infective T. cruzi
forms/mice obtaining the same results (data not shown).
Therefore, mice lacking TLR4 expression in a C57BL genetic
background are more sensitive than their WT controls to infection
with T. cruzi, although these strains do not display the uncontrolled
parasitemia and the remarkable earlier mortality previously
observed in the TLR4-mutant C3H/HeJ mice [5].
Splenocytes from infected TLR4-deficient mice produce
lower NO levels than WT mice. NO inhibition in vivo
makes WT and TLR4-deficient mice equally susceptible to
infection
We then analyzed whether a lower NO production by the
infected TLR4-deficient mice could explain their higher suscep-
tibility to infection as suggested by the results obtained in vitro. In
accordance with that hypothesis, the production of NO (inferred
from nitrite levels in the supernatants) by spleen cells from infected
Figure 1. Equal invasion rate but increased growth of T. cruzi in
TLR4-deficient macrophages. (A) 105 resident peritoneal macro-
phages from TLR4-deficient strains C3H/HeJ, C57BL/10ScN, or TLR42/2
mice and from their respective WT controls (C3H/HePas, C57BL/10, or
C57BL/6) were cultured in the presence of blood form trypomastigotes
of the Y strain in a 1:10 (macrophage:trypomastigotes) ratio, for 1 h, as
described in Materials and Methods. After that period, extracellular
trypomastigotes were removed by washing and the cells were fixed and
stained with Giemsa. The percentage of infected macrophages and the
intracellular parasite numbers in 100 macrophages were counted under
a light microscope. (B–G) Cells were infected with blood form
trypomastigotes of the Y (C–G) or CL strains (B) as described in (A).
Thioglycollate elicited peritoneal macrophages from B6 and TLR42/2
mice were cultured in (G). After removal of extracellular trypomasti-
gotes by extensive washing, cultures were continued for several days
and the number of trypomastigotes released into the supernatants was
determined daily from day 5 on. Each data point is expressed as the
mean6 SEM of triplicates and experiments shown are representative of
at least two independent experiments.
doi:10.1371/journal.ppat.1000870.g001
Cytotoxic CD8 Response to T. cruzi in Myd882/2 Mice
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TLR4-deficient mice was significantly reduced when compared
with NO released by spleen cells from infected WT mice at day 10
post-infection (Figure 5A and B). Nitrite levels are also lower in the
sera of TLR4-deficient mice, compared to WT animals, at this
time point of infection (data not shown). Furthermore, the in vivo
blockade of NO production in T. cruzi infected animals, by
injection of the inducible NO synthase (iNOS) inhibitor amino-
guanidine (AG) in the early phase of acute infection, brought the
parasitemia and mortality of treated WT mice to the same levels
obtained in treated Tlr42/2 animals (Figure 5C and D). In
animals injected every other day with AG, following a previously
reported protocol [17], parasitemia kept rising until treatment was
stopped on day 13 pi, attaining 3 and 7 fold higher levels of what
was usually observed in Tlr42/2 and WT non-treated animals,
respectively (Figure 5C). This is due to the prevention of all NO
generation, as for example in response to TLR2 and/or TLR9
signaling pathways, rather than exclusive inhibition of NO
triggered by TLR4 engagement. Also, while non-treated infected
animals usually die only after day 20 pi, earlier mortality was
observed among AG-treated mice, with 50% mortality in both
Tlr42/2 and WT AG-treated groups by day 12 pi (Figure 5D).
Hence, these results suggest that the lower NO production due to
Figure 2. TLR4 is associated with T. cruzi that entered lysosomal compartments. HEK293-TLR4YFP cells were infected with TO-PRO-3 labeled
trypomastigotes at 1:10 ratio. 2 h later, non-internalized parasites were removed by washing and cells were stained with LysoTracker Red for 0.5 h.
Confocal sections were collected and the intracellular distribution of TLR4YFP and T. cruzi was analyzed. (A) TO-PRO-3-labeled trypomastigotes (blue)
are uniformly dispersed inside the infected cells as shown by phase contrast microscopy (B). In (C) and (D) we see the subcellular distribution of
TLR4YFP (green) and LysoTracker-stained lysosomes (red) in HEK293-infected cells, respectively. Note in (E) several trypomastigotes (blue) co-localized
with TLR4 (green) inside lysosomes (red). White arrows indicate two trypomastigotes, for illustration. Calibration bar: 20 mm.
doi:10.1371/journal.ppat.1000870.g002
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the absence of TLR4 expression during the early phase of
infection with T. cruzi is responsible for the higher sensitivity
observed in Tlr42/2 mice.
The frequency of IFN-c producing CD8+ T cells is not
reduced in infected TLR4-deficient mice, although total
spleen levels of IFN-c and TNF-a are
As IFN-c is thought to be the most important inducer of iNOS
in macrophages and thus essential for mediation of NO-dependent
parasite control during acute infection [18], we quantified IFN-c
production by spleen cells from WT and TLR4-deficient infected
mice. As shown in Figure 6A, higher IFN-c levels are indeed
secreted by WT infected splenocytes at day 10 pi. We also
compared the secretion of another crucial cytokine for iNOS
expression and host resistance to T. cruzi, TNF-a [14] As shown in
Figure 6B, the levels of TNF-a secreted by splenocytes from
infected WT mice are also significantly higher than from TLR4-
deficient mice. Both IFN-c and TNF-a can be produced after T.
cruzi-induced triggering of the innate immune response (mainly by
NK/NKT cells and macrophages/DC respectively), as well as by
CD8+ and CD4+ T lymphocytes later in the infection course, as
part of the acquired response to the parasite. Since several
previous studies have demonstrated the importance of IFN-c
secretion by CD8+ T cells in resistance to infection with T. cruzi
[19], we asked if the frequency of Ag-specific IFN-c-secreting cells
would be altered in the absence of TLR4 expression. To do so, a
previously defined H-2Kb-restricted epitope (PA8) derived from
the amastigote surface protein-2 (ASP2), which is a member of the
trans-sialidase family of surface proteins, was employed in
ELISPOT assays [20]. However, as shown in Figure 6C no
significant difference in the frequency Ag-specific IFN-c secreting
cells could be observed between WT and TLR4-deficient infected
mice. Two other previously described trans-sialidase-derived
peptides TSKB20 and TSKB18 [21] were alternatively employed
in ELISPOT assays, giving the same results (not shown). The
frequency of IFN-c secreting CD4+ and CD8+ T cells in the
spleens of WT and TLR4-deficient mice at day 13 pi was also
investigated by intracellular staining and results are shown in
Figure 6D-G. These data show that the frequencies of CD4+ and
CD8+ T cells secreting IFN-c in response to T. cruzi-derived
antigens are not reduced in Tlr42/2 mice.
The frequency of defined peptide/H-2Kb-restricted IFN-c
secreting lymphocytes is not decreased in Tlr2 2/2, Tlr42/2,
Tlr92/2 or Myd882/2 infected mice, nor is cytotoxicity
At this point, the present investigation was extended to compare
the frequency of PA8/Kb-specific IFN-c secreting lymphocytes
between WT and mice which are deficient in other members of
the TLR family, as well as Myd882/2 mice, whose susceptibility to
T. cruzi infection was previously described [6,7]. To our surprise,
the frequency of these important effector cells of the acquired
response is not altered in the spleens of Tlr22/2, Tlr92/2 or
Myd882/2 mice, as with Tlr4-deficient mice (Figure 7A). We also
estimated the percentage of IFN-c secreting CD8+ T cells in the
spleen of infected Myd882/2 mice at day 10 pi by intracellular
cytokine staining (ICS) following in vitro stimulation with PA8
peptide and obtained the same results, that is, no significant
difference in the frequency of IFN-c+CD8+cells between WT B6
and Myd882/2 mice (Fig. 7B–D). In order to further evaluate the
adaptive response to T. cruzi in Myd882/2 mice, the percentage of
IFN-c secreting T cells was measured by ICS in both CD4+ and
CD8+ subsets at days 11 and 13 pi. As shown in Figure 8, although
the absence of MyD88 signaling strongly affects the percentage of
CD4+ IFN-c cells in these mice, MyD88 expression is not essential
for the differentiation of IFN-c producing CD8+ T cells specific
against T. cruzi-derived epitopes. Finally, we tested whether
expansion of specific CD8+ cytotoxic T cells was affected in any
of the above Tlr2/2 or Myd882/2 mice. For this purpose, we used
a functional cytotoxic assay which measures the in vivo elimination
of target cells (total splenocytes) coated either with PA8 (Figs. 9A
and C), TSKB20 or TSKB18 (Fig. 9B) peptides, as previously
described [21]. The phenotype of effector cells mediating peptide-
specific in vivo cell killing was established earlier as being CD8+ T
cells [22]. The kinetics of Ag-specific cytotoxic CD8+ T cell
development during infection with the Y strain of T. cruzi in mice
was also previously determined, showing that the maximum
cytotoxicity (close to 100% specific lysis) is attained around day 15
pi and continued at a high level in B6 mice, even until 100 days
after challenge [22]. As shown in Fig. 9B, at day 20 post-infection,
Figure 3. Defective early trypanosomacidal mechanism in
TLR4-deficient macrophages. (A) Resident macrophages from
C3H/HePas (wt) and C3H/HeJ (Tlr4d/d) mice were infected with blood
form trypomastigotes of the Y strain in the presence of L-NMMA (1 mM)
and/or DFO (100 mM), according to the legend and as detailed in the
Materials and Methods section. After 4 h of culture, cells were fixed and
stained with Giemsa. Asterisk (*) indicates that the percentage of
infected MO is significantly different (p,0.05) between WT and TLR4-
deficient cultures without treatment. (B) Resident peritoneal macro-
phages from B6 and Tlr42/2 mice were infected with blood form
trypomastigotes of the Y strain, as described in Fig. 1, with (closed
symbols) or without (open symbols) L-NMMA (1 mM). The number of
trypomastigotes released into the supernatants was assessed daily from
day 5 on. Each data point is expressed as the mean 6 SEM of triplicates
and experiments shown are representative of at least two independent
ones.
doi:10.1371/journal.ppat.1000870.g003
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no difference in peptide-specific cytotoxicity could be detected
between Tlr42/2 and WT mice for any of the tested peptides. The
same was true for Myd882/2 mice, in which the in vivo cytotoxicity
assay was performed at an earlier post-infection time point (day 10
pi) due to their earlier mortality [7] (Fig. 9B). A summary of the
cytotoxicity experiments is shown in Figure 9C, where the results
of specific killing obtained with the PA8 immunodominant peptide
in Tlr22/2, Tlr4 2/2, Tlr92/2 or Myd882/2 mice are compared
to B6 controls. No difference in the levels of specific cytotoxicity
was observed in any of these deficient mice. Together, these results
clearly indicate that deficiency in TLR2, TLR4, TLR9 or even
MyD88 expression does not impair CD8+ T cell effector responses
during infection with T. cruzi.
Discussion
Different T. cruzi-derived molecules are able to induce host
innate immune responses through the activation of different
members of the TLR family, [3–6,23], including glycoinositolpho-
spholipids derived from the parasite membrane which induce a
pro-inflammatory response through the TLR4 pathway [5,23].
Thus, the documented high susceptibility of Myd882/2 mice to
infection with T. cruzi could not be attributed to a single TLR,
suggesting that different members of the TLR family act in concert
in determining resistance to the pathogen [6]. Bafica and
collaborators have shown that doubly deficient Tlr22/2 Tlr92/2
mice, although more susceptible than the single TLR2- or TLR9-
deficient mice, do not display the acute mortality exhibited by
Myd882/2 mice, suggesting that additional TLR/IL-1R family
members are involved in the protection against infection with T.
cruzi in mice [6]. In this context, the contribution of TLR4
signaling to control of the parasite burden in the C57BL/6
background was not investigated until the present study, as the
only previous work on the subject was performed in mice of a
different genetic background [5]. Importantly, the present work is
the first to study the contribution of the different TLR and MyD88
Figure 4. Enhanced susceptibility of Tlr42/2 mice to infection with T. cruzi parasites. Groups of 5 or more male 6-wk-old mice from B6 (wt)
(A, C and H), Tlr42/2 (B, C and H), B10 (wt) (D, F and G) and C57BL/10ScN (E, F and G) strains of mice were infected with 26103 trypomastigote of
the Y strain of T. cruzi and parasitemia (A–F) as well as mortality (G and H) were assessed daily. Parasitemia values of each mouse are shown in (A, B,
D and E). (C) and (F) represent the mean values of individual parasitemia shown in (A and B), and (D and E), respectively. Mortality curves (G) were
statistically different (p,0.05). The results shown are representative of three independent experiments.
doi:10.1371/journal.ppat.1000870.g004
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pathways to the development of anti-T. cruzi responses mediated
by CD8+ effector T cells, a critical element of the acquired
immune response to the parasite.
The first question we addressed was to assess the role of TLR4
in T. cruzi internalization and triggering of very early microbicidal
activity by macrophages. Infective T. cruzi trypomastigotes invade
host cells using at least two different strategies; either by an active
process recruiting host-cell lysosomes to the area of parasite cell
contact or by an alternative pathway, in which the parasite infects
phagocytic cells through conventional phagocytosis/endocytosis
mechanism [24–26]. In both cases, the parasite may escape to the
cytoplasm where it differentiates into the aflagellated amastigote
form and begins intracellular replication. During cell invasion, T.
cruzi interacts with different macrophage receptors to induce its
own phagocytosis, but the nature of those receptors and the
molecular mechanisms involved are still poorly understood.
Although the general current view is that TLRs do not function
directly as phagocytic receptors [27], a recent report indicated that
during the invasion of T. cruzi, the activation of the Rab5-
dependent phagocytic pathway is regulated by signals emanated
through the parasite interaction with TLR2 in macrophages [28].
Our present results with Tlr4-deficient macrophages from three
different mouse strains show that internalization of T. cruzi by
macrophages is not affected by the absence of functional TLR4
expression. Some studies on the other hand, have demonstrated
that TLR signaling by means of MyD88 can enhance phagosome
acidification and function, the so-called phagosome maturation,
which is required for effective sterilization of its contents [29]. In
accord with those results, we found that after 2.5 h of infection,
TLR4 and parasite co-localize into acidic compartments. Also, 4 h
after infection, the percentage of TLR4-deficient macrophages
infected with T. cruzi is significantly higher when compared to WT
cells. The addition of iNOS or ROS inhibitors abolished the
difference in the frequency of infected macrophages between
cultures from TLR4-deficient and WT origin, indicating that this
early trypanosomicidal mechanism triggered by TLR4 depends on
the production of reactive nitrogen intermediates (RNI) and ROS,
which have been described to participate in the microbicidal
activity against T. cruzi and other pathogens [12–15]. Moreover,
the fact that the simultaneous usage of iNOS and ROS inhibitors
Figure 5. In vivo blockage of NO production turns WT and Tlr42/2 mice equally susceptible to infection with T. cruzi. (A) and (B) show
the levels of nitrite in the supernatant from splenocyte cultures from TLR4-deficient C3H/HeJ and C57BL/10ScN, respectively, at 10 days post infection
(pi) with T. cruzi and compared to their WT controls. Asterisk (*) indicates that difference is statistically significant (p#0.01). (C) Parasitemia and (D)
Survival curves of infected B6 and Tlr42/2 mice treated (or not) every other day with aminoguanidine (AG) from the beginning of infection until day
13 pi. Black arrows in (C) and (D) indicate the day when the treatment was stopped. The results shown are representative of two different
experiments.
doi:10.1371/journal.ppat.1000870.g005
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Figure 6. Preserved IFN-c-producing CD8+and CD4+ T cell frequencies but reduced total IFN-c and TNF-a levels in infected Tlr42/2
mice. Levels of cytokines (A) IFN-c and (B) TNF-a, in the supernatant of splenocyte cultures from TLR4-deficient C57BL/10ScN mice (triangles)
compared to the WT control, B10 mice (squares), at day 10 pi. Asterisk (*) indicates that the difference is statistically significant (p,0.05). (C) IFN-c
producing spleen cells specific to the PA8 peptide were estimated by the ELISPOT assay. Results obtained in C57BL/10ScN (white bars) and their wt
controls B10 mice (black bars), uninfected or at day 20 pi. The results represent the mean number of peptide-specific spot forming cells (SFC) per 105
splenocytes + SD (n = 4). (D–G) IFN-c intracellular staining. (D) CD4 and CD8 dot plot gates. (E) Dot plot of IFN-c staining and isotype controls of CD4+
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did not increase further the percentage of infected macrophages,
suggests that the peroxynitrite anion (ONOO2), a strong oxidizing
and against T. cruzi, formed by the reaction between nitric oxide
(NO) and superoxide radical (O22), may be the main species
responsible for the elimination of T. cruzi, as described [30,31]cy-
totoxic effector molecule. Therefore, TLR4 signaling triggers an
important early parasiticidal event against T. cruzi, which is
dependent on the formation of NO and ROS. Significantly lower
production of NO was also found in splenocyte cultures from
Tlr42/2 mice at day 10 post infection. In conformity to these
or CD8+ spleen cells from WT infected mouse at day 13 pi, gated as in (D). (F and G) The ratio of IFN-c+CD8+ cells within the CD8+ population (F) or of
IFN-c+CD4+ cells within the CD4+ population (G) was calculated for each mouse and condition: (2) unstimulated, or (+) stimulated with PA8 (F), or
stimulated with T. cruzi extract (G), respectively. Results are expressed as the mean + SD of four to six animals per group. WT, black bars, Tlr42/2,
white bars. Results of uninfected mice or isotype controls of both strains are shown in gray bars.
doi:10.1371/journal.ppat.1000870.g006
Figure 7. IFN-c production by CD8+ T splenocytes is equivalent in infected Myd882/2and WT mice. (A) IFN-c producing spleen cells
specific to the PA8 peptide were estimated by the ELISPOT assay in B6 (wt) and Tlr22/2, Tlr42/2, Tlr92/2, or Myd882/2 mice, at days 15, 15, 15 and 10
pi, respectively. Values represent mean of DSFC (SFC obtained in the presence of PA8 peptide minus SFC obtained in the absence of peptide) per 105
splenocytes + SD (n = 4 or 3). Results are representative of two or more independent experiments. IFN-c production by CD8+ splenocytes from T.
cruzi-infected (day 10 pi) Myd882/2 or WT mice was assessed following a 14-h in vitro incubation with or without PA8 peptide. After surface staining
with PerCP-conjugated anti-CD8 mAb, the cells were fixed, permeabilized and then stained with PE-conjugated anti- IFN-c mAb, and analyzed by flow
cytometry. (B) Cells were gated on lymphocyte population (FSC6SSC) and CD8+ as shown. (C) CD8 versus IFN-c dot-plot of gated cells: numbers
indicate the percentage of IFN-c-producing and non-producing CD8+ cells, within the CD8+ population. Data are representative of individual
Myd882/2and WT mice, stimulated with peptide (PA8) or not (ctr). (D) The ratio of IFN-c+CD8+ cells within the CD8+ population was calculated for
each mouse and condition (unstimulated, white bars or stimulated with PA8, gray bars) and results are expressed as the mean + SD of three to five
animals per group.
doi:10.1371/journal.ppat.1000870.g007
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results, we demonstrated that Tlr42/2 splenocyte cultures produce
lower levels of the main iNOS inducer cytokines, IFN-c and TNF-
a. As with the in vitro results obtained with macrophage cultures,
the inhibition of NO production during in vivo infection made WT
and Tlr42/2 mice equally susceptible, as measured by mortality
and parasite levels in the blood. Our results are in agreement with
previous studies demonstrating that mice deficient for inducible
nitric oxide synthase (iNOS) are highly susceptible to T. cruzi [32],
and that the inhibition of iNOS from the beginning of infection
lead to an increase in trypomastigotes in the blood and to high
mortality [15,33]. Together, our results point to a significant
contribution of the TLR4 pathway to the innate immune response
against T. cruzi infection, with the production of NO playing a
major role.
We show that mice of either B10 or B6 genetic background with
TLR4 deficiency presented significantly elevated parasite numbers
in the blood compared to their WT controls after in vivo infection
with T. cruzi. These results are in accordance with our previous
work showing higher parasitemia levels of the Tlr4 mutant C3H/
HeJ mice [5], although this is more pronounced in the latter
lineage. Concerning mortality, however, the absence of functional
TLR4 expression in B10 or B6 mice do not lead to the acute
mortality previously observed in C3H/HeJ mice [5]. Therefore,
the effects of TLR4 deficiency on susceptibility to infection with T.
cruzi are more evident in the C3H background. Inbred strains of
mice may vary from highly resistant to highly susceptible, as
reflected by parasitemia levels and survival time and, following
these criteria, C3H strains have been classified as ‘‘susceptible’’.
Classical genetic studies previously established that the resistance
to T. cruzi is governed by multiple genetic factors, including H-2-
linked gene(s) [34,35] and the combination of different alleles in a
group of loci confers resistance or susceptibility to infection.
Therefore, analogous to the effects due to the absence of TLR2,
which only become perceptible in mice with the concomitant
deficiency on TLR9 [6], we have shown here that the susceptibility
resulting from the absence of TLR4 is less pronounced in the
resistant B6 and B10 backgrounds, compared to C3H strains.
IFN-c is an important mediator of resistance to T. cruzi. Besides
iNOS, IFN-c regulates the expression of a large number of genes,
including chemokines and chemokine receptors, which were
shown to play a role in IFN-c-mediated protection in T. cruzi
infection [18,32,36]. Early during infection, IFN-c is secreted by
NK cells and other cell types, as part of the innate response, and
later on the infection course by activated CD4+ and CD8+ T cells.
Since TLRs have been implicated in the modulation of acquired
immunity against several pathogens, we have herein addressed the
question of whether the frequencies of IFN-c secreting CD8+ and
CD4+ T cells are altered in Tlr42/ mice. Our data showed no
significant difference in the frequencies of IFN-c producing CD8+
or CD4+ T cells in the spleens of Tlr42/2 and WT mice,
indicating that TLR4 deficiency does not interfere with these
important effectors of the acquired response against T. cruzi.
Therefore, the higher level of IFN-c detected in the supernatants
of WT splenocyte cultures at day 10 pi is probably contributed by
cells of the innate response. A number of different cells types may
account for that and we are currently evaluating their phenotype.
On the other hand, a significant reduction in the levels of the
IFN-c+CD4+ T cell population was observed in the spleens of
Myd882/2 infected mice. This finding is in line with previous in
vitro experiments [6], but contrasts to the results of a recent paper,
where IFN-c production by CD4+ T cells is shown to be preserved
in Myd882/2 mice infected with the Tulahuen strain of T. cruzi
[37]. The reason for this apparent discrepancy is not clear and
could be due to the different strain of parasite used for infection or
to the method employed for CD4+ T cell re-stimulation in vitro.
Therefore, our results demonstrate that although the CD4+ T cell-
mediated response is substantially diminished, unaltered frequen-
cies of CD8+ IFN-c T cells specific for Kb-restricted T. cruzi-
derived peptides are present in the spleens of Myd882/2 mice
compared to WT controls at days 10, 11 and 13 pi.
CD8+ T cell mediated responses are a critical component of
protective immunity in T. cruzi infection, since in their absence
Figure 8. Preserved IFN-c production by CD8+ T cells but
impaired IFN-c CD4+ response in Myd882/2 mice at days 11 and
13 pi. IFN-c production by CD8+ (A and C) and CD4+ (B and D)
splenocytes from T. cruzi-infected Myd882/2 or WT (B6) mice was
assessed following a 5-h in vitro incubation with (+) or without (2) PA8
peptide (A and C) or T. cruzi extract (B and D), respectively, at days 11
(A and B) and 13 (C and D) pi. After surface staining with PerCP-
conjugated anti-CD8 or FITC-conjugated anti-CD4 mAb, the cells were
fixed, permeabilized and then stained with PE-conjugated anti-IFN-c
mAb, and analyzed by flow cytometry. Cells were gated on lymphocyte
population (FSC6SSC) and CD8+ or CD4+ as shown in Fig. 6. The ratio of
IFN-c+CD8+ cells within the CD8+ population and the ratio of IFN-
c+CD4+ cells within the CD4+ population was calculated for each mouse
and condition (WT, black bars, Myd882/2, white bars) and results are
expressed as the mean 6 SD of four to six animals per group.
Uninfected controls of both strains were pooled and shown in gray
bars. Asterisk (*) indicates that the percentage of IFN-c+CD4+ is
significantly different (p,0.05) between WT and Myd882/2 mice,
treated (+) or not (2) with T. cruzi extract.
doi:10.1371/journal.ppat.1000870.g008
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Figure 9. Specific cytotoxicity against immunodominant peptides in infected Tlr2/2 or Myd882/2 mice. (A) In vivo cytotoxicity assays by
cytometry. Normal splenocytes labeled with two concentrations of CFSE (CFSElow and CFSEhigh) were injected intravenously into infected mice.
CFSEhigh cells (M2 population) were pulsed with the Kb-restricted PA8 peptide derived from T. cruzi ASP-2 protein. CFSElow cells (M1 population) were
unpulsed and served as internal controls. Percentage of specific cell lysis was measured 20 hr later by FACS, as described in the Materials and
Methods section. (B) The percentage of specific cell killing obtained in vivo in infected Tlr42/2 or MyD882/2 mice at days 20 and 10 pi, respectively,
and in their WT control, B6 mice, using PA8-, TSKB20- or TSKB18-pulsed target cells. Results are expressed as the mean of three to nine animals per
group, each symbol representing an individual mouse. (C) Percentage of specific in vivo cell killing obtained in Tlr22/2, Tlr42/2, Tlr92/2 or MyD882/2
mice (white bars) and in their wt control, B6 mice (black bars), using PA8-pulsed target cells at days 15, 15, 15 and 10 pi, respectively. Results are
expressed as the mean + SD of three to five animals per group. Results are representative of three or more independent experiments.
doi:10.1371/journal.ppat.1000870.g009
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mice quickly succumb to the infection or develop a more severe
chronic disease (reviewed in [19]). Moreover, CD8+ T cells can be
induced by vaccination to provide protection from lethal infection
[38]. CD8+ T cells can control infection via a number of
mechanisms: in addition to the already discussed secretion of IFN-
c inducing microbicidal activity in the host cell, the direct
cytotoxic function against cells infected with T. cruzi is also a main
effector response. Therefore, it is an important issue to define
whether TLR-MyD88 mediated pathways can play a role in the
priming and/or control of the cytotoxic T cell response against T.
cruzi-infected targets. According to the present paradigm, this
could be mainly achieved by the engagement of TLRs on antigen-
presenting cells (APCs) such as dendritic cells (DCs), promoting
upregulation of co-stimulatory molecules, enhancement of antigen
processing and presentation, as well as secretion of Th1 polarizing
pro-inflammatory cytokines by the DCs [2]. We demonstrated
here, however, that the cytotoxic response mediated by CD8+ T
cells against H-2Kb-restricted immunodominant peptides in T.
cruzi infected mice is not dependent on TLR2, TLR4 nor TLR9
expression. Unexpectedly, the Ag-specific cytotoxic function was
also preserved in Myd882/2 mice. As the cytotoxic response
against the immunodominant PA8 T. cruzi epitope tested here was
previously shown to be dependent on MHC class II restricted
CD4+ T cells [39], our results indicate that although diminished in
frequency, the residual response of CD4+ activated T cells
observed in infected Myd882/2 mice is sufficient for their licensing
function, which results in the development of parasite-specific
CD8+mediated cytotoxic response. A first possible interpretation
of these results is that none of the tested TLR and MyD88
pathways are involved in the generation of cytotoxic CD8+ T cells
during T. cruzi infection. In fact, other signaling molecules and
innate recognition systems might contribute to adaptive immunity
to T. cruzi as the members of the Nod-like receptor protein (NLR)
family [40]. Other examples are: 1) the release of pro-
inflammatory bradykinin peptide by the parasite proteases during
infection and consequent DC maturation induced by bradykinin
B2 receptors (B2R) [41] and 2) the recently described DC
maturation induced by NFATc1 activation and consequent IFN-c
production in a TLR-independent pathway [37]. However, to
date, it was not determined if these TLR-independent pathways
can fully account for the preserved CD8+ T cell cytotoxic response
against T. cruzi-infected targets observed in Myd882/2 mice.
In our opinion, there is another plausible hypothesis to be
considered for explaining the preserved CD8+ T cell cytotoxic
response in Tlr22/2, Tlr42/2, Tlr92/2 or Myd882/2 mice: it is
known that type I IFNs affect DC maturation [42,43] and can also
stimulate survival, development of cytolytic function, and
production of IFN-c by CD8+ T cells [44,45]. Moreover, mice
deprived of the type I IFN receptor, Ifnar2/2, develop higher
parasitemia levels in comparison with control 129Sv mice [46] and
doubly deficient Myd882/2Ifnar2/2 mice are highly susceptible to
infection with T. cruzi [8]. Both TLR9 and TLR4 could induce
type I IFN secretion through MyD88-dependent and -independent
pathways, respectively. Therefore, TLR4 and TLR9 would be
redundant concerning type I IFN production and might
compensate for each other’s absence in Tlr42/2 or Tlr92/2 mice.
The TLR4-triggered TRIF pathway is also preserved in
Myd882/2 mice and its activation would lead to type I IFN
secretion and DC maturation, with the consequent normal
adaptive responses against T. cruzi in these mice. Testing whether
the CD8-mediated cytotoxicity against T. cruzi is affected in
Tlr42/2Tlr92/2 or Tlr42/2Myd882/2 doubly deficient mice is
one of our future goals. According to this hypothesis, cytotoxic
CD8+ T cells would not be preserved in doubly deficient
Myd882/2Trif2/2 mice, which is in agreement with the fact that
these mice are even more susceptible to infection, as indicated by
accelerated mortality when compared to single Myd882/2 mice
[8]. Also, in opposition to Myd882/2, the doubly deficient
Myd882/2Trif2/2 mice are not able to control the levels of
parasite in the blood [8].
The maintenance of CD8+ acquired responses against T. cruzi in
Myd882/2 mice finds a parallel in studies of murine infection with
Toxoplasma gondii, another intracellular protozoan parasite. As for T.
cruzi, multiple TLR ligands were identified in T. gondii and Myd882/2
mice were shown to be highly susceptible to infection (reviewed in
[47]). Interestingly, a recent work demonstrated that a robust and
protective IFN-c response can be elicited in Myd882/2 mice infected
with an avirulent T. gondii strain [48]. Therefore, the MyD88
pathway is required for innate immunity to control infection with
Toxoplasma, even though adaptive immunity against the pathogen can
be triggered without the need for this TLR adaptor molecule. The
same picture emerges from our present results with T. cruzi. The
absence of a role for the MyD88 pathway in the generation of CD8+
adaptive responses during T. cruzi infection is also in line with other
previous reports analyzing the immune response to other pathogens
[49,50], including the described protective CD8+ T cell response
against the intracellular bacteria Listeria [51].
The preservation of CD8+ T cell mediated effector mechanisms
in MyD88-deficient mice is in agreement with the fact that despite
their high mortality, these mice do succeed in controlling the
number of parasites in the blood, in contrast to the even more
susceptible Ifng2/2, IfngR2/2, iNos2/2 or Myd882/2Trif2/2 mice
[8,32,36]. At present we do not know why Myd882/2mice
succumb earlier than WT mice and display 100% mortality to
T. cruzi infection, notwithstanding their capacity of controlling
blood parasitemia [7] and their preserved CD8+ T cell-mediated
responses shown here. We would like to consider four non-
exclusive possibilities: First, Myd882/2mice, whose IFN-c levels in
serum were shown to be significantly lower [7], would also be
affected by the fact that several genes, like iNOS and IP-10, have
been shown to be 5- to 100-fold less extensively induced by IFN-c
in macrophages lacking MyD88 expression [52]. Second, the
higher susceptibility of Myd882/2 mice could be directly
attributed to the defective activation of CD4+ T cells demonstrated
here, as this cell population has also been demonstrated to be
essential for resistance to infection [53], probably through IFN-c
and TNF-a secretion. We do not know at the present what
mechanism, absent in Myd882/2 mice, affects CD4+ T cell
activation. Both attenuated DC maturation due to the absence of
TLRs/MyD88 triggering and the absence of IL-1R/IL-18R
signaling in CD4+ Myd882/2 T cells should be considered. Third,
the lower levels of CD4+ helpers might also have indirect
consequences as a defect in the B cell mediated response, which
was also described to be necessary for resistance to the parasite
[54]. In fact, although controversy exists, the requirement of TLR-
MyD88 signaling for the generation of T-dependent antigen-
specific antibody responses was proposed [55,56] and, interest-
ingly, antibody responses against different virus are altered or
completely lost in Myd882/2 mice [57–59]. Finally, another
possible consequence of a deficiency in CD4+ cell activation could
be the defective migration of CTLs into peripheral sites of
infection distinct of the spleen (liver and heart, for example), as
recently demonstrated by Nakanishi et al. in a mouse model of
herpes simplex virus (HSV) infection of the vagina [60].
In summary, the results obtained in the present study strongly
argue in favor of a role for the TLR4 signaling in the innate
immune response against T. cruzi displayed by B6 mice. Notably,
we have also shown here that neither the absence of TLR2, TLR4
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or TLR9 individually, nor the ablation of all MyD88-mediated
pathways affect the development of cytotoxic and IFN-c-
producing CD8+ T cells, which are crucial effector mechanisms
against this parasite. Determining precisely how TLR-TRIF-
MyD88 activation contributes to trigger protective immunity
against T. cruzi will be of critical relevance for vaccine
development against this important human parasite.
Materials and Methods
Mice and ethics statement
All animal experiments were approved by and conducted in
accordance with guidelines of the Animal Care and Use
Committee of the Federal University of Rio de Janeiro (Comiteˆ
de E´tica do Centro de Cieˆncias da Sau´de CEUA -CCS/UFRJ).
Tlr22/2, Tlr42/2, Tlr92/2 and Myd882/2 mice were generated
by and obtained from Dr. S. Akira (Osaka University, Japan) via
Dr. R. T. Gazzinelli (Federal University of Minas Gerais, Brazil).
Tlr22/2 and Tlr42/2 mice were maintained along C57BL/6 mice
at the Laborato´rio de Animais Transgeˆnicos (LAT, IBCCFu,
UFRJ, RJ, Brazil). C3H/HeJ and C3H/HePas mice were from
ICB, Universidade de Sa˜o Paulo (USP, SP, Brazil). C57BL/10
and C57BL/10ScN mice were maintained at the Biote´rio of the
Department of Immunology (IMPPG, UFRJ, RJ, Brazil). Tlr92/2
and Myd882/2 mice were maintained at the Centro de Pesquisas
Rene´ Rachou (FIOCRUZ, MG, Brazil).
Parasite and experimental infection
Mice used for experiments were sex- and age-matched, and
housed with a 12-h light-dark cycle. Bloodstream trypomastigotes
of the Y strain of T. cruzi [61] were obtained from BALB/c mice
infected 7 days earlier. The concentration of parasites was
estimated and each mouse (at least 4 per group) was inoculated
intraperitoneally (i.p.) with 0.2 ml (26103 trypomastigotes).
Parasitemia was monitored by counting the number of blood-
stream trypomastigotes in 5 ml of fresh blood collected from the
tail vein. Mouse survival was followed daily.
In vitro infection
Resident or elicited macrophages (obtained from the peritoneal
cavity on day 4 after injection of 2.5 ml of 3% thioglycollate)
were plated in triplicates and infected with trypomastigotes at a
1:10 (macrophage:trypomastigote) ratio. After 1 h of infection,
the cells were washed four times with PBS to remove the
extracellular parasites and cultured in DMEM supplemented
with 10% FBS (GIBCO, Invitrogen) for the indicated time
periods at 37uC in an atmosphere containing 5% CO2.
Trypomastigotes in the culture supernatants were counted
microscopically in triplicates. Alternatively, extracellular parasites
were removed by repeated washing after 1 h of infection and the
cells were either washed, fixed and stained with Giemsa or
cultured for a further 4 h in DMEM supplemented with 10%
FBS before fixation and staining. In other experiments,
macrophages were infected for 1 h in the presence of L-NMMA
(1 mM) and/or DFO (100 mM); after washing, cells were cultured
for further 4 h in DMEM supplemented with 10% FBS in the
presence of L-NMMA (1 mM) and/or DFO (100 mM) and
subsequently fixed and stained with Giemsa. The percentage of
infected macrophages and the intracellular parasite numbers in
100 macrophages were counted under a light microscope.
Confocal microscopy
The stable cell line of HEK293 cells expressing the fluorescent
protein TLR4YFP and MD-2 constructs were described previ-
ously [11] and kindly donated by Dr D. Golenbock (University of
Massachusetts Medical School, MA). Trypomastigotes were
labeled with TO-PRO-3 (1 ml/ml, Molecular Probes, Invitrogen)
for 30 min at RT, washed twice and then cultured with HEK-
TLR4YFP cells at 10:1 ratio for 1 hour at 37uC, 5% CO2. After
repeated washing with PBS for extracellular parasite removal,
cells were stained with LysoTracker Red probe (75 nM,
Molecular Probes, Invitrogen) for 1 hour. Cells were then
washed in PBS containing 1 mM MgCl2 and 1 mM CaCl2
and fixed in 3,7% paraformaldehyde/PBS for 15 min. Confocal
microscopy was performed with a Zeiss Axiovert 200-M inverted
microscope equipped with an LSM 510 Meta laser-scanning
unit. Image analysis was performed with LSM 510 software
(Zeiss).
Griess reaction for RNI quantification
The Griess reaction was performed to quantitate nitrite
concentrations in the supernatant of macrophage or spleen cell
cultures, as previously described [62]. Briefly, 50 ml of sample plus
50 ml of Griess reagent were incubated for 10 min at RT, followed
by detection at 550 nm in an automated ELISA plate reader. The
results are expressed in units of micromolar, and were determined
comparing the absorbance readings of the experimental samples to
a sodium nitrate standard curve.
Inhibition of iNOS in vivo
Inhibition of iNOS in vivo was performed by injecting mice i.p.
with 50 mg/kg of aminoguanidine/body weight, (AG, Sigma-
Aldrich, St. Louis), diluted in sterile phosphate-buffered saline
(PBS), every other day, as previously described [20]. Treatment
started 4 h before infection with T. cruzi (performed as described
above), and animals were treated until day 13 pi. Control mice
received the same volume (200 ml) of PBS. A third group of mice
received AG only.
ELISPOT
The ELISPOT assay was performed essentially as described
earlier [63]. Briefly, the preparation of plates was done by
coating 96-well nitrocellulose plates Multiscreen HA (Millipore)
with 60 ml/well of sterile PBS containing 10 mg/ml of the anti-
mouse IFN-c mAb R4-6A2 (BD Biosciences, San Jose, CA).
After overnight incubation at RT, mAb solution was removed
by sterile aspiration and the plates were washed three times with
plain RPMI 1640 medium under sterile conditions. Plates were
blocked by incubating wells with 100 ml RPMI medium
containing 10% (v/v) FBS for at least 2 h at 37uC. Responder
cells were obtained from spleens of B6 mice. Responder cells
were ressuspended to a concentration of 106 viable cells per ml
in RPMI medium (GIBCO, Invitrogen) supplemented with
10 mM HEPES, 2 mM L-glutamine, 561025 M 2-b-mercap-
toethanol, 1 mM sodium pyruvate, 100 U/ml of penicillin and
streptomycin, 10% (v/v) FBS (all purchased from GIBCO,
Invitrogen). B6 spleen cells adjusted to a concentration of 46106
viable cells per ml were used as antigen presenting cells after
incubation or not with the synthetic peptide at a final
concentration of 10 mM for 30 min at 37uC. One hundred
microliters of suspension containing responders or antigen
presenting cells were pipetted into each well. The plates were
incubated for 24 h at 37uC in an atmosphere containing 5%
CO2. After incubation, the bulk of cultured cells was flicked out.
To remove residual cells, plates were washed 3 times with PBS
and 3 times with PBS-Tween. Each well received 75 ml of
biotinylated anti-mouse IFN-c mAb XMG1.2 (BD Biosciences)
diluted in PBS-Tween to a final concentration of 2 mg/ml.
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Plates were incubated overnight at 4uC. Unbound antibodies
were removed by washing the plates at least 6 times with PBS-
Tween. Peroxidase-labeled streptavidin (KPL) was added at a
1:800 dilution in PBS-Tween in a final volume of 100 ml/well.
Plates were incubated for 1–2 h at RT and then washed three to
five times with PBS-Tween and three times with PBS. Plates
were developed by adding 100 ml/well of peroxidase substrate
(50 mM Tris–HCl at pH 7.5 containing 1 mg/ml of DAB and
1 ml/ml of 30% hydrogen peroxide solution, both from Sigma).
After incubation at RT for 15 min, the reaction was stopped by
discarding the substrate solution and rinsing the plates under
running tap water. Plates were dried at RT and spots were
counted with the aid of a stereomicroscope (Nikon) or in the
ImmunoSpotH Analyzer (Cellular Technology Ltd., Shaker
Heights, OH, USA). Results of the ELISPOT assay are
representative of two or more independent experiments.
Generation of T. cruzi amastigote extract
Tissue culture trypomastigotes of the Y strain of T. cruzi were
transformed to amastigotes in acidic DMEM/10% FCS for 24 h
at 37uC, as previously described [64]. Parasites were pelleted,
washed in PBS, and subjected to more than five rounds of
freeze-thawing followed by sonication. Cellular debris were
removed by centrifugation at 12,000 rpm, and the soluble
fraction was boiled for 5 min to denature the proteins. Protein
concentrations were determined using a Bio-Rad protein
assay.
Intracellular cytokine staining
Splenocytes isolated from infected mice were cultured either
with T. cruzi amastigote extract at 10 mg/ml (see above) or with
PA8 peptide (VNHRFTLV) at 10 mM, or left unstimulated, for
5 h to 14 h at 37uC in the presence of brefeldin A (Sigma-Aldrich).
Cells were surface stained with anti-CD8-PerCP and anti-CD4-
FITC (BD Biosciences) and fixed for 10 minutes with a solution
containing PBS, 4% paraformaldehyde at RT. Then, cells were
permeabilized for 15 minutes with PBS, 0.1% bovine serum
albumine, 0.1% saponin (Sigma-Aldrich). Intracellular cytokine
staining was performed with anti- IFN-c -PE (BD Biosciences). At
least 10,000 gated CD8+ lymphocyte events were acquired.
Analytical flow cytometry was conducted with a FACSCalibur
(BD Biosciences) and the data were processed with CellQuest
software (BD Biosciences).
In vivo cytotoxicity assay
For the in vivo cytotoxicity assays, splenocytes of the different
mouse strains were divided into two populations and labeled with
the fluorogenic dye CFSE (Molecular Probes, Invitrogen) at a final
concentration of 5 mM (CFSEhigh) or 0.5 mM (CFSElow). CFSEhigh
cells were pulsed for 40 min at 37uC with 1–2.5 mM of either H-
2Kb -restricted ASP-2 peptide, also called PA8, (VNHRFTLV),
H-2Kb- restricted TsKb-18 peptide (ANYDFTLV) or H-2Kb-
restricted TsKb-20 peptide (ANYKFTLV). CFSElow cells re-
mained unpulsed. Subsequently, CFSEhigh cells were washed and
mixed with equal numbers of CFSElow cells before injecting i.v.
15–206106 total cells per mouse. Recipient animals were mice
that had been infected or not with T. cruzi. Spleen cells of recipient
mice were collected 20 h after transfer, fixed with 2.0%
paraformaldehyde and analyzed by cytometry, using a FACSCa-
libur Cytometer (BD Biosciences). Percentage of CFSElow (M1)
and CFSEhigh (M2) cells were obtained using CellQuest software
(BD Biosciences). Percentage of specific lysis was determined using
the formula: 1 - ((M2infected/M1infected)/(M2naı¨ve/M1naive))
6100%.
Statistical analysis
Statistical analyses were performed using GraphPad Prism
version 4.00 for Windows (GraphPad Software, San Diego
California USA, www.graphpad.com). Data were compared using
a two-tailed Student’s t test and are expressed as mean 6 SEM.
Data were considered statistically significant if p values were
,0.05. The LogRank test was used to compare the mouse survival
rate after challenge with T. cruzi. The differences were considered
significant when the P value was ,0.05.
Supporting Information
Figure S1 Early trypanosomacidal mechanism is absent in
TLR4-deficient macrophages. (A) Resident macrophages from
C3H/HePas (wt, black bars) and C3H/HeJ (Tlr4d/d, white bars)
mice were infected with blood form trypomastigotes of the Y
strain in a 1:10 (macrophage:trypomastigotes) ratio, for 1 h. After
this period, extracellular trypomastigotes were removed by
washing and the cells were fixed and stained with Giemsa (1 h).
Alternatively, after washing, cultures were prolonged for a total 4-
h incubation time, after which cells were fixed and stained with
Giemsa (4 h). (B) Resident macrophages from C57BL/10 (wt,
black bars) and C57BL/10ScN (Tlr42/2, white bars) were
infected and treated as in (A). The percentage of infected
macrophages was counted under a light microscope and each
data point is expressed as the mean + SEM of triplicates.
Experiments shown are representative of at least two independent
experiments. One asterisk (*) indicates that the percentage of
infected MO is significantly different (p,0.05) between WT and
TLR4-deficient MO after the 4 h period of culture. Two asterisks
(**) indicate that the percentage of infected MO is significantly
different (p,0.05) between WT MO cultivated by 1 h and 4 h
periods of culture.
Found at: doi:10.1371/journal.ppat.1000870.s001 (0.61 MB TIF)
Figure S2 IFN-cturns WT and Tlr42/2 MO equally resistant
to infection with T. cruzi. 105 resident peritoneal macrophages
from Tlr42/2 mice and from their WT controls (C57BL/6)
were cultured in the presence of trypomastigotes of the Y strain
in a 1:10 (macrophage:trypomastigotes) ratio, for 1 h. After
removal of extracellular trypomastigotes by extensive washing,
cultures were continued for several days and the number of
trypomastigotes released into the supernatants was determined
daily from day 10 on. In some triplicates, rmIFN-c (2.0 ng/ml)
was added to the cultures from the beginning (black symbols).
Asterisks (*) indicate that the number of trypomastigotes
released into the supernatants is significantly different
(p,0.05) between WT and TLR4-deficient MO cultures. Each
data point is expressed as the mean 6 SEM of triplicates and
experiments shown are representative of at least two indepen-
dent experiments.
Found at: doi:10.1371/journal.ppat.1000870.s002 (0.76 MB TIF)
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